ISA247 Is Safe And Effective In Treating Psoriasis
Ina phase III trial, a new treatment for moderate to severe plaquepsoriasis has been proven safe and effective. Additionally, there isalmost a linear relationship between drug dose and response, whichsuggests that patients can be accurately dosed in order to achieve aclinical response while minimizing side effects. These results werepublished on April 18, 2008 in The Lancet.
This post is an original post by ScienceDaily: Skin Care News
Posted: April 19th, 2008 under skin health.
Comments: none
